Dangdai International Group Co. Ltd 13D and 13G filings for CELLULAR BIOMEDICINE GROUP, IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-19 7:50 pm Sale |
2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
Dangdai International Group Co. Ltd | 0 0.000% |
-2,270,000 (Position Closed) |
Filing |
| 2020-08-12 11:16 am Unchanged |
2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
Dangdai International Group Co. Ltd | 2,270,000 11.700% |
0 (Unchanged) |
Filing |
| 2020-06-24 7:31 pm Unchanged |
2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
Dangdai International Group Co. Ltd | 2,270,000 11.800% |
0 (Unchanged) |
Filing |